ReviewFrontiers in oncology2026
Circulating tumor DNA for minimal residual disease and recurrence surveillance in hepatocellular carcinoma: current evidence and a translational roadmap.
Yang Gu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.